Wordt geladen...
Cyclizing-berberine A35 induces G2/M arrest and apoptosis by activating YAP phosphorylation (Ser127)
BACKGROUND: A35 is a novel synthetic cyclizing-berberine recently patented as an antitumor compound. Based on its dual targeting topoisomerase (top) activity, A35 might overcome the resistance of single-target top inhibitors and has no cardiac toxicity for not targeting top2β. In this study we furth...
Bewaard in:
| Gepubliceerd in: | J Exp Clin Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935996/ https://ncbi.nlm.nih.gov/pubmed/29728107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0759-6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|